WuXi PharmaTech Invests in TruTag for On-Dose Authentication Technology
WuXi PharmaTech (Cayman) Inc., a pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, and TruTag Technologies, Inc., developer of an edible, covert security platform for product counterfeiting challenge announced that WuXi Corporate Venture Fund has made an investment in TruTag. In addition, WuXi and TruTag will explore collaborations to offer WuXi’s global customers the TruTag on-dose authentication solution to help prevent counterfeiting and to enhance drug safety.
TruTag microtags are inert and edible and can integrate into the fabric of a product without packaging or labels for the authentication of food, drugs, electronics, consumer products, and industrial components. Using this technology, brand owners, including pharmaceutical companies, will be able to field-read finished tablets circulating in the wholesale and retail market to determine the authenticity and provenance of medicines, including detailed information such as site and date of manufacture, lots, and other critical data.
Source: WuXi PharmaTech